NexImmune (NEXI) News Today $0.25 -0.07 (-21.79%) (As of 10:38 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Shattuck Labs stock craters following pipeline and job cutsOctober 3, 2024 | msn.comNexImmune moves forward with wind-down processAugust 31, 2024 | bizjournals.comNexImmune adjourns special meeting to explore optionsAugust 4, 2024 | investing.comNEXI Stock Alert: NexImmune Delists From NasdaqJuly 12, 2024 | investorplace.comWhat Is Going on With NexImmune (NEXI) Stock Today?July 11, 2024 | investorplace.comNexImmune, Inc. Common Stock (NEXI) After-HoursMay 26, 2024 | nasdaq.comNEXI Stock Earnings: NexImmune Reported Results for Q1 2024May 20, 2024 | msn.comNEXI Stock Earnings: NexImmune Reported Results for Q4 2023April 17, 2024 | investorplace.comAcute Myeloid Leukemia Market Size is Expected to Grow by 2032 | DelveInsightApril 16, 2024 | theglobeandmail.comPortage mulls company closure, pauses enrolment for lead clinical programmeApril 15, 2024 | msn.comXilio fires 21% of its workforce and reprioritises pipelineApril 2, 2024 | msn.comNexImmune Announces New Offerings in Recent Press ReleaseFebruary 7, 2024 | msn.comNexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesFebruary 6, 2024 | markets.businessinsider.comNexImmune Secures Funding Through Equity and Warrant SalesFebruary 6, 2024 | msn.comNexImmune Ends Stock Sale Agreement, Raises $5.1 MillionFebruary 3, 2024 | msn.comNexImmune slips after securities offeringFebruary 2, 2024 | msn.comNexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesFebruary 2, 2024 | finance.yahoo.comTrading was temporarily halted for "NEXI" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 2, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause." Trading set to resume at 10:01 AM. January 31, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 02:01 PM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 11:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 10:01 AM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 12:01 PM with a stated reason of "LULD pause." Trading set to resume at 12:01 PM. January 29, 2024 | marketbeat.comNexImmune, Inc. Common Stock (NEXI)January 13, 2024 | nasdaq.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 10, 2024 | marketbeat.comNexImmune (NEXI) Stock Rockets 80% Ahead of Potential LiquidationJanuary 9, 2024 | investorplace.comTrading was temporarily halted for "NEXI" at 10:01 AM with a stated reason of "LULD pause."January 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 5, 2024 | marketbeat.comNexImmune's future in limbo as Gaithersburg biotech extends liquidation voteDecember 26, 2023 | bizjournals.comNexImmune, Inc. (NEXI) Stock Price, News, Quote & History - Yahoo FinanceDecember 10, 2023 | ca.finance.yahoo.comTrading was temporarily halted for "NEXI" at 09:12 AM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 02:12 PM with a stated reason of "LULD pause."December 1, 2023 | marketbeat.comNEXI Stock Halted: What’s Going on With NexImmune Shares Today?December 1, 2023 | investorplace.comWhy Is NexImmune (NEXI) Stock Up 353% Today?December 1, 2023 | investorplace.comTrading was temporarily halted for "NEXI" at 08:12 AM with a stated reason of "News pending."December 1, 2023 | marketbeat.comNexImmune Inc Ordinary Shares NEXINovember 23, 2023 | morningstar.comGaithersburg’s NexImmune prepares to shut down, lay off ‘substantially all’ employeesNovember 8, 2023 | bizjournals.comWhat's Going On With Neximmune (NEXI) Stock Monday?November 6, 2023 | msn.comWhy Neximmune (NEXI) Stock Is Getting HammeredNovember 3, 2023 | msn.comNexImmune Shares Slide Premarket as Biotech Says It Will LiquidateNovember 3, 2023 | marketwatch.comTrading was temporarily halted for "NEXI" at 10:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comNexImmune, Yale, and JDRF Extend Research Partnership for Type 1 DiabetesOctober 24, 2023 | finance.yahoo.comNexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual MeetingOctober 19, 2023 | finance.yahoo.com Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address "January Surprise" Could Cut Bull Run Short, Says Banking Expert (Ad)According to one of America's most trusted banking experts – followed by names at Wells Fargo, UBS, and Barclays – the U.S. economy could look very different by January 20. Click here to see Dan's warning (and possible solution) for America. NEXI Media Mentions By Week NEXI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEXI News Sentiment▼0.000.57▲Average Medical News Sentiment NEXI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEXI Articles This Week▼00▲NEXI Articles Average Week Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aditxt News Today Revelation Biosciences News Today TFF Pharmaceuticals News Today PaxMedica News Today ASLAN Pharmaceuticals News Today Ayala Pharmaceuticals News Today Panbela Therapeutics News Today ZyVersa Therapeutics News Today Evofem Biosciences News Today Onconetix News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEXI) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexImmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.